CLINICAL_TRIALS
research
· 2023-05-03
Clinical Trial Update: Granulocyte Colony Stimulating Factor Four Week Plus N-Acetyl Cysteine in Severe Alcoholic Hepatitis [Phase 4]
Summary
A Phase 4 trial evaluating granulocyte colony-stimulating factor with N-acetylcysteine in severe alcoholic hepatitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Alcoholic Hepatitis | Phase 4 | Status: COMPLETED